Eleven Biotherapeutics Appoints Gary Sternberg, M.D., M.B.A., As Executive Vice President Corporate And Business Development

Published: May 05, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Eleven Biotherapeutics (NASDAQ:EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced the appointment of Gary J. Sternberg, M.D., M.B.A. as Executive Vice President of Corporate and Business Development. Dr. Sternberg brings more than 20 years of ophthalmology expertise including biotechnology and pharmaceutical industry experience and medical practice.

Help employers find you! Check out all the jobs and post your resume.

Back to news